{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:54:22Z","timestamp":1785329662321,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key Laboratory Construction Project of Shanxi Province","award":["zyyyjs2024035"],"award-info":[{"award-number":["zyyyjs2024035"]}]},{"name":"Traditional Chinese Medicine Innovation Team of Shanxi Province","award":["zyytd2024021"],"award-info":[{"award-number":["zyytd2024021"]}]},{"name":"High-levels Talents of Shanxi University of Chinese Medicine","award":["2023RC03"],"award-info":[{"award-number":["2023RC03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09688-y","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T12:02:09Z","timestamp":1718366529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Human umbilical cord mesenchymal stem cells promoted tumor cell growth associated with increased interleukin-18 in hepatocellular carcinoma"],"prefix":"10.1007","volume":"51","author":[{"given":"Yanguang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuman","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"9688_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3892\/mmr.2019.10286","volume":"20","author":"YT Guan","year":"2019","unstructured":"Guan YT, Xie Y, Li DS et al (2019) Comparison of biological characteristics of mesenchymal stem cells derived from the human umbilical cord and decidua parietalis. Mol Med Rep 20:633\u2013639. https:\/\/doi.org\/10.3892\/mmr.2019.10286","journal-title":"Mol Med Rep"},{"key":"9688_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/cyto.a.23242","volume":"93","author":"D Mushahary","year":"2018","unstructured":"Mushahary D, Spittler A, Kasper C, Weber V, Charwat V (2018) Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytometry A 93:19\u201331. https:\/\/doi.org\/10.1002\/cyto.a.23242","journal-title":"Cytometry A"},{"key":"9688_CR3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.biopha.2017.04.126","volume":"91","author":"P Shende","year":"2017","unstructured":"Shende P, Subedi M (2017) Pathophysiology, mechanisms and applications of mesenchymal stem cells for the treatment of spinal cord injury. Biomed Pharmacother 91:693\u2013706. https:\/\/doi.org\/10.1016\/j.biopha.2017.04.126","journal-title":"Biomed Pharmacother"},{"key":"9688_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00441-017-2699-4","volume":"372","author":"D Bharti","year":"2018","unstructured":"Bharti D, Shivakumar SB, Park JK et al (2018) Comparative analysis of human Wharton\u2019s jelly mesenchymal stem cells derived from different parts of the same umbilical cord. Cell Tissue Res 372:51\u201365. https:\/\/doi.org\/10.1007\/s00441-017-2699-4","journal-title":"Cell Tissue Res"},{"key":"9688_CR5","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/jog.13432","volume":"43","author":"FA Dabrowski","year":"2017","unstructured":"Dabrowski FA, Burdzinska A, Kulesza A et al (2017) Comparison of the paracrine activity of mesenchymal stem cells derived from human umbilical cord, amniotic membrane and adipose tissue. J Obstet Gynaecol Res 43:1758\u20131768. https:\/\/doi.org\/10.1111\/jog.13432","journal-title":"J Obstet Gynaecol Res"},{"key":"9688_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13287-017-0668-1","volume":"8","author":"X Sun","year":"2017","unstructured":"Sun X, Hao H, Han Q et al (2017) Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats. Stem Cell Res Ther 8:241. https:\/\/doi.org\/10.1186\/s13287-017-0668-1","journal-title":"Stem Cell Res Ther"},{"key":"9688_CR7","doi-asserted-by":"publisher","first-page":"116133","DOI":"10.1016\/j.biopha.2024.116133","volume":"171","author":"P Chen","year":"2024","unstructured":"Chen P, Yuan M, Yao L et al (2024) Human umbilical cord-derived mesenchymal stem cells ameliorate liver fibrosis by improving mitochondrial function via Slc25a47-Sirt3 signaling pathway. Biomed Pharmacother 171:116133. https:\/\/doi.org\/10.1016\/j.biopha.2024.116133","journal-title":"Biomed Pharmacother"},{"key":"9688_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10238-016-0427-0","volume":"17","author":"D Wang","year":"2017","unstructured":"Wang D, Niu L, Feng X et al (2017) Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study. Clin Exp Med 17:333\u2013340. https:\/\/doi.org\/10.1007\/s10238-016-0427-0","journal-title":"Clin Exp Med"},{"key":"9688_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/5584_2019_343","volume":"1084","author":"TT Dao","year":"2019","unstructured":"Dao TT, Nguyen CT, Vu NB, Le HT, Nguyen PD, Van Pham P (2019) Evaluation of proliferation and osteogenic differentiation of human umbilical cord-derived mesenchymal stem cells in porous scaffolds. Adv Exp Med Biol 1084:207\u2013220. https:\/\/doi.org\/10.1007\/5584_2019_343","journal-title":"Adv Exp Med Biol"},{"key":"9688_CR10","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.18240\/ijo.2021.11.20","volume":"14","author":"J Yang","year":"2021","unstructured":"Yang J, Ren XJ, Chen XT et al (2021) Human umbilical cord-derived mesenchymal stem cells treatment for refractory uveitis: a case series. Int J Ophthalmol 14:1784\u20131790. https:\/\/doi.org\/10.18240\/ijo.2021.11.20","journal-title":"Int J Ophthalmol"},{"key":"9688_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.brainres.2013.08.001","volume":"1532","author":"S Wang","year":"2013","unstructured":"Wang S, Cheng H, Dai G et al (2013) Umbilical cord mesenchymal stem cell transplantation significantly improves neurological function in patients with sequelae of traumatic brain injury. Brain Res 1532:76\u201384. https:\/\/doi.org\/10.1016\/j.brainres.2013.08.001","journal-title":"Brain Res"},{"key":"9688_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13287-018-0888-z","volume":"9","author":"M Lim","year":"2018","unstructured":"Lim M, Wang W, Liang L et al (2018) Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction. Stem Cell Res Ther 9:129. https:\/\/doi.org\/10.1186\/s13287-018-0888-z","journal-title":"Stem Cell Res Ther"},{"key":"9688_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.17179\/excli2023-6538","volume":"23","author":"A Hassanzadeh","year":"2024","unstructured":"Hassanzadeh A, Shomali N, Kamrani A et al (2024) Detailed role of mesenchymal stem cell (MSC)-derived exosome therapy in cardiac diseases. Excli j 23:401\u2013420. https:\/\/doi.org\/10.17179\/excli2023-6538","journal-title":"Excli j"},{"key":"9688_CR14","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.4049\/jimmunol.1300667","volume":"191","author":"LJ Mathias","year":"2013","unstructured":"Mathias LJ, Khong SM, Spyroglou L et al (2013) Alveolar macrophages are critical for the inhibition of allergic asthma by mesenchymal stromal cells. J Immunol 191:5914\u20135924. https:\/\/doi.org\/10.4049\/jimmunol.1300667","journal-title":"J Immunol"},{"key":"9688_CR15","doi-asserted-by":"publisher","first-page":"39889","DOI":"10.1038\/srep39889","volume":"7","author":"H Zhu","year":"2017","unstructured":"Zhu H, Xiong Y, Xia Y et al (2017) Therapeutic effects of Human umbilical cord-derived mesenchymal stem cells in Acute Lung Injury mice. Sci Rep 7:39889. https:\/\/doi.org\/10.1038\/srep39889","journal-title":"Sci Rep"},{"key":"9688_CR16","first-page":"E71","volume":"23","author":"S Atluri","year":"2020","unstructured":"Atluri S, Manchikanti L, Hirsch JA (2020) Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ill COVID-19 patients: the case for compassionate use. Pain Physician 23:E71\u2013e83","journal-title":"Pain Physician"},{"key":"9688_CR17","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.3892\/ijmm.2018.3500","volume":"41","author":"LT Zhang","year":"2018","unstructured":"Zhang LT, Peng XB, Fang XQ, Li JF, Chen H, Mao XR (2018) Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro. Int J Mol Med 41:2545\u20132552. https:\/\/doi.org\/10.3892\/ijmm.2018.3500","journal-title":"Int J Mol Med"},{"key":"9688_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.yrtph.2016.09.029","volume":"81","author":"JW Yun","year":"2016","unstructured":"Yun JW, Ahn JH, Kwon E et al (2016) Human umbilical cord-derived mesenchymal stem cells in acute liver injury: hepatoprotective efficacy, subchronic toxicity, tumorigenicity, and biodistribution. Regul Toxicol Pharmacol 81:437\u2013447. https:\/\/doi.org\/10.1016\/j.yrtph.2016.09.029","journal-title":"Regul Toxicol Pharmacol"},{"key":"9688_CR19","doi-asserted-by":"publisher","first-page":"6982","DOI":"10.3892\/ol.2018.8254","volume":"15","author":"Q Li","year":"2018","unstructured":"Li Q, Pang Y, Liu T et al (2018) Effects of human umbilical cord-derived mesenchymal stem cells on hematologic malignancies. Oncol Lett 15:6982\u20136990. https:\/\/doi.org\/10.3892\/ol.2018.8254","journal-title":"Oncol Lett"},{"key":"9688_CR20","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.3892\/mmr.2016.5537","volume":"14","author":"YM Tang","year":"2016","unstructured":"Tang YM, Bao WM, Yang JH et al (2016) Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells. Mol Med Rep 14:2717\u20132724. https:\/\/doi.org\/10.3892\/mmr.2016.5537","journal-title":"Mol Med Rep"},{"key":"9688_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"9688_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16:589\u2013604. https:\/\/doi.org\/10.1038\/s41575-019-0186-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9688_CR23","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1007\/s11010-021-04206-1","volume":"476","author":"T Ali","year":"2021","unstructured":"Ali T, Saxena R, Rani I et al (2021) Association of interleukin-18 genotypes (-607C\u2009>\u2009A) and (-137 G\u2009>\u2009C) with the hepatitis B virus disease progression to hepatocellular carcinoma. Mol Cell Biochem 476:3923\u20133933. https:\/\/doi.org\/10.1007\/s11010-021-04206-1","journal-title":"Mol Cell Biochem"},{"key":"9688_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/intimm\/12.2.151","volume":"12","author":"K Tominaga","year":"2000","unstructured":"Tominaga K, Yoshimoto T, Torigoe K et al (2000) IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int Immunol 12:151\u2013160. https:\/\/doi.org\/10.1093\/intimm\/12.2.151","journal-title":"Int Immunol"},{"key":"9688_CR25","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.4049\/jimmunol.160.10.4738","volume":"160","author":"M Tomura","year":"1998","unstructured":"Tomura M, Zhou XY, Maruo S et al (1998) A critical role for IL-18 in the proliferation and activation of NK1.1\u2009+\u2009CD3- cells. J Immunol 160:4738\u20134746","journal-title":"J Immunol"},{"key":"9688_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/s0165-2478(01)00278-4","volume":"79","author":"H Park","year":"2001","unstructured":"Park H, Byun D, Kim TS et al (2001) Enhanced IL-18 expression in common skin tumors. Immunol Lett 79:215\u2013219. https:\/\/doi.org\/10.1016\/s0165-2478(01)00278-4","journal-title":"Immunol Lett"},{"key":"9688_CR27","first-page":"51","volume":"17","author":"SA Eissa","year":"2005","unstructured":"Eissa SA, Zaki SA, El-Maghraby SM, Kadry DY (2005) Importance of serum IL-18 and RANTES as markers for breast carcinoma progression. J Egypt Natl Canc Inst 17:51\u201355","journal-title":"J Egypt Natl Canc Inst"},{"key":"9688_CR28","doi-asserted-by":"publisher","unstructured":"Xiang S, Li J, Shen J et al (2021) Identification of prognostic genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Front Immunol 12. https:\/\/doi.org\/10.3389\/fimmu.2021.653836","DOI":"10.3389\/fimmu.2021.653836"},{"key":"9688_CR29","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1038\/sj.bjc.6602596","volume":"92","author":"JM Arnold","year":"2005","unstructured":"Arnold JM, Huggard PR, Cummings M, Ramm GA, Chenevix-Trench G (2005) Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma. Br J Cancer 92:2024\u20132031. https:\/\/doi.org\/10.1038\/sj.bjc.6602596","journal-title":"Br J Cancer"},{"key":"9688_CR30","doi-asserted-by":"publisher","unstructured":"Li K, Li T, Feng Z et al (2021) CD8(+) T cell immunity blocks the metastasis of carcinogen-exposed breast cancer. Sci Adv 7. https:\/\/doi.org\/10.1126\/sciadv.abd8936","DOI":"10.1126\/sciadv.abd8936"},{"key":"9688_CR31","doi-asserted-by":"publisher","first-page":"216043","DOI":"10.1016\/j.canlet.2022.216043","volume":"559","author":"Q Wang","year":"2023","unstructured":"Wang Q, Qin Y, Li B (2023) CD8(+) T cell exhaustion and cancer immunotherapy. Cancer Lett 559:216043. https:\/\/doi.org\/10.1016\/j.canlet.2022.216043","journal-title":"Cancer Lett"},{"key":"9688_CR32","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","volume":"184","author":"Y Sun","year":"2021","unstructured":"Sun Y, Wu L, Zhong Y et al (2021) Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell 184:404\u2013421e416. https:\/\/doi.org\/10.1016\/j.cell.2020.11.041","journal-title":"Cell"},{"key":"9688_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/hep.28874","volume":"65","author":"J Bergmann","year":"2017","unstructured":"Bergmann J, M\u00fcller M, Baumann N et al (2017) IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice. Hepatology 65:89\u2013103. https:\/\/doi.org\/10.1002\/hep.28874","journal-title":"Hepatology"},{"key":"9688_CR34","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","volume":"11","author":"LT Li","year":"2015","unstructured":"Li LT, Jiang G, Chen Q, Zheng JN (2015) Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep 11:1566\u20131572. https:\/\/doi.org\/10.3892\/mmr.2014.2914","journal-title":"Mol Med Rep"},{"key":"9688_CR35","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2119\/molmed.2010.00157","volume":"17","author":"K Suzuki","year":"2011","unstructured":"Suzuki K, Sun R, Origuchi M et al (2011) Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med 17:579\u2013587. https:\/\/doi.org\/10.2119\/molmed.2010.00157","journal-title":"Mol Med"},{"key":"9688_CR36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","volume":"25","author":"RN Apte","year":"2006","unstructured":"Apte RN, Dotan S, Elkabets M et al (2006) The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 25:387\u2013408. https:\/\/doi.org\/10.1007\/s10555-006-9004-4","journal-title":"Cancer Metastasis Rev"},{"key":"9688_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/intimm\/dxw006","volume":"28","author":"K Hirahara","year":"2016","unstructured":"Hirahara K, Nakayama T (2016) CD4\u2009+\u2009T-cell subsets in inflammatory diseases: beyond the Th1\/Th2 paradigm. Int Immunol 28:163\u2013171. https:\/\/doi.org\/10.1093\/intimm\/dxw006","journal-title":"Int Immunol"},{"key":"9688_CR38","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C et al (2012) Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS ONE 7:e47559. https:\/\/doi.org\/10.1371\/journal.pone.0047559","journal-title":"PLoS ONE"},{"key":"9688_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/scrt221","volume":"4","author":"T Zhang","year":"2013","unstructured":"Zhang T, Lee YW, Rui YF, Cheng TY, Jiang XH, Li G (2013) Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors. Stem Cell Res Ther 4:70. https:\/\/doi.org\/10.1186\/scrt221","journal-title":"Stem Cell Res Ther"},{"key":"9688_CR40","doi-asserted-by":"publisher","first-page":"e4992","DOI":"10.1371\/journal.pone.0004992","volume":"4","author":"EL Spaeth","year":"2009","unstructured":"Spaeth EL, Dembinski JL, Sasser AK et al (2009) Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS ONE 4:e4992. https:\/\/doi.org\/10.1371\/journal.pone.0004992","journal-title":"PLoS ONE"},{"key":"9688_CR41","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/s12885-016-2595-4","volume":"16","author":"C Liu","year":"2016","unstructured":"Liu C, Liu Y, Xu XX, Guo X, Sun GW, Ma XJ (2016) Mesenchymal stem cells enhance the metastasis of 3D-cultured hepatocellular carcinoma cells. BMC Cancer 16:566. https:\/\/doi.org\/10.1186\/s12885-016-2595-4","journal-title":"BMC Cancer"},{"key":"9688_CR42","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1038\/srep02298","volume":"3","author":"B Ljujic","year":"2013","unstructured":"Ljujic B, Milovanovic M, Volarevic V et al (2013) Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice. Sci Rep 3:2298. https:\/\/doi.org\/10.1038\/srep02298","journal-title":"Sci Rep"},{"key":"9688_CR43","doi-asserted-by":"publisher","first-page":"236","DOI":"10.22074\/cellj.2020.6313","volume":"22","author":"M Fakhimi","year":"2020","unstructured":"Fakhimi M, Talei AR, Ghaderi A, Habibagahi M, Razmkhah M (2020) Helios, CD73 and CD39 Induction in Regulatory T Cells exposed to adipose derived mesenchymal stem cells. Cell J 22:236\u2013244. https:\/\/doi.org\/10.22074\/cellj.2020.6313","journal-title":"Cell J"},{"key":"9688_CR44","doi-asserted-by":"publisher","first-page":"107823","DOI":"10.1016\/j.intimp.2021.107823","volume":"97","author":"M Arabpour","year":"2021","unstructured":"Arabpour M, Saghazadeh A, Rezaei N (2021) Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes. Int Immunopharmacol 97:107823. https:\/\/doi.org\/10.1016\/j.intimp.2021.107823","journal-title":"Int Immunopharmacol"},{"key":"9688_CR45","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s-Morales VA, Ch\u00e1vez-S\u00e1nchez L, Rocha-Zavaleta L et al (2023) Mesenchymal Stem\/Stromal Cells Derived from Cervical Cancer Promote M2 Macrophage Polarization. Cells https:\/\/doi.org\/10.3390\/cells12071047","DOI":"10.3390\/cells12071047"},{"key":"9688_CR46","first-page":"329","volume":"4","author":"S Park","year":"2007","unstructured":"Park S, Cheon S, Cho D (2007) The dual effects of interleukin-18 in tumor progression. Cell Mol Immunol 4:329\u2013335","journal-title":"Cell Mol Immunol"},{"key":"9688_CR47","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/nm.2028","volume":"15","author":"F Ghiringhelli","year":"2009","unstructured":"Ghiringhelli F, Apetoh L, Tesniere A et al (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 15:1170\u20131178. https:\/\/doi.org\/10.1038\/nm.2028","journal-title":"Nat Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09688-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09688-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09688-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T03:34:46Z","timestamp":1738726486000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09688-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9688"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09688-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal research plan has been permitted by the Ethics Committee for Animal Experiment of Shanxi University of Chinese Medicine (AWE202311402).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"762"}}